Studies with Affected Status Descriptions – NIDA Center for Genetic Studies

Studies with Affected Status Definitions

You may use the following filters:

Study:

Title:

Collection:

Affected Status Description:

id	Study	Title	Collection	Affected Status Description
1	1	Genetics of Opioid Dependence	Opioid-Cocaine Dependence	DSM Opioid or Cocaine Dependence
2	2	Mapping Susceptibility Genes for Nicotine Dependence	Nicotine Dependence	DSM Nicotine Dependence or FTND>=4
3	3	Molecular Genetics of Heroin Dependence in China	Opioid Dependence	DSM Opioid Dependence
4	5	Addictions, Genotypes, Polymorphisms, and Function	Opioid Dependence	DSM Opioid Dependence
5	6	The Genetics of Vulnerability to Nicotine	Nicotine Dependence	DSM Nicotine Dependence or FTND>=4
6	7	An Introduction to the Family Study of Cocaine	Cocaine Dependence	DSM Cocaine Dependence
8	9	Differentiation of Phenotypes for Smoking: Administrative Supplement to Join NIDA Genetics Consortium	Nicotine Dependence	DSM Nicotine Dependence or FTND>=4 or 5 cigs/day for 5 years and current 6 months
9	10	Pharmacokinetics of Nicotine in Twins	Nicotine Dependence	DSM Nicotine Dependence or FTND>=4
10	11	Adolescent Drug Dependence	Polysubstance Dependence	DSM Opioid, Cocaine, Cannabis, Stimulant, Sedative, or other dependence
11	12	Substance Abuse and the Dopamine System Genes	Polysubstance Dependence	DSM Opioid, Cocaine, Cannabis, Stimulant, Sedative, or other dependence
12	13	Genetics of Cocaine Induced Psychosis	Cocaine Dependence	DSM Cocaine Dependence
13	14	Genome-Wide Analysis for Addiction Susceptibility Genes	Opioid Dependence	DSM Opioid Dependence
14	15	Nicotine Dependence	Nicotine Dependence	DSM Nicotine Dependence or FTND>=4
15	16	Nicotine Dependence	Nicotine Dependence	DSM Nicotine Dependence or FTND>=4
16	17	Opioid Dependence	Opioid Dependence	DSM Opioid Dependence
17	18	Opioid Dependence: Candidate Genes and G x E Effects	Opioid Dependence	DSM Opioid Dependence
18	19	Epidemiological Study of Substance Abuse	Polysubstance Dependence	DSM Opioid, Cocaine, Cannabis, Stimulant, Sedative, or other dependence
19	20	Innovative Approaches for Cocaine Pharmacotherapy	Opioid-Cocaine Dependence	DSM Opioid or Cocaine Dependence
22	23	Substance Use Disorder Liability: Candidate Gene System	Polysubstance Dependence	DSM Opioid, Cocaine, Cannabis, Stimulant, Sedative, or other dependence
23	24	START Pharmacogenetics: Exploratory Genetic Studies in Starting Treatment with Agonist Replacement Therapies (START); CTN-0027	Opioid Dependence	DSM Opioid Dependence
26	27	The Genetic Study of Nicotine Dependence in African Americans (AAND)	Nicotine Dependence	DSM Nicotine Dependence or FTND>=4
28	29	Genetics Protocol of the Cocaine Use Reduction with Buprenorphine (CURB) Study; CTN-0048	Cocaine Dependence	DSM Cocaine Dependence
31	32	Achieving Cannabis Cessation-Evaluation of N-Acetylcysteine (ACCENT); CTN-0053	Cannabis Dependence	DSM Cannabis Dependence
34	35	Genetically Informative Smoking Cessation Trial	Nicotine Dependence	Active smoking (Cigarettes Per Day [CPD] ≥5) and exhaled Carbon Monoxide [CO] ≥8 ppm
	Study	Title	Collection	Affected Status Description